-
effectivehealthcare.ahrq.gov/products/adhd-heart-disease-children/research
December 12, 2011 - Research Network), we identified 150,658 adults aged 25-64 years with prescriptions for methylphenidate, amphetamines … Adjusted rate ratios for current use of methylphenidate, amphetamines or atomoxetine vs. non-use of any
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-children_research.pdf
January 01, 2023 - Adjusted rate ratios for current use of methylphenidate, amphetamines or
atomoxetine vs. non-use of … myocardial infarction, and death are among the top 50 most commonly reported
adverse events for both amphetamines … Current use was further categorized based on specific medications (amphetamines,
methylphenidate, atomoxetine … Fully adjusted rate ratios of MI or SCD for current use of amphetamines,
methylphenidate and atomoxetine … increased risk for
current use of any of the specific medications examined (i.e., methylphenidate, amphetamines
-
effectivehealthcare.ahrq.gov/products/attention-deficit-hyperactivity-disorder/draft-comments
August 17, 2021 - Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents
Key Questions Draft August 17, 2021 Download Main Document PDF 449.6 KB
This report is available in PDF only ( Draft Key Questions [PDF, 449.6 KB]).
Background
The Patient-Centered Outcomes Research In…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/deficit-hyperactivity.pdf
January 01, 2019 - Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in
Children and Adolescents
Background
The Patient-Centered Outcomes Research Institute (PCORI) is partnering with AHRQ to update
a systematic evi…
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/deficit-hyperactivity.pdf
January 01, 2019 - Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in
Children and Adolescents
Background
The Patient-Centered Outcomes Research Institute (PCORI) is partnering with AHRQ to update
a systematic evi…
-
effectivehealthcare.ahrq.gov/products/suicide-prevention/research-protocol
December 28, 2015 - Current Page Topic Timeline Sep. 18, 2015 Topic Initiated Dec. 28, 2015 Research Protocol Oct. 4, 2016 Systematic Review Feb. 9, 2017 Disposition of Comments Report Suicide Prevention
Research Protocol Archived December 28, 2015 Download Main Document PDF 1.3 MB
Archived: This report is greater than …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research-protocol.pdf
December 23, 2015 - Untitled
Source: www.effectivehealthcare.ahrq.gov
Published online: December 23, 2015
Evidence-based Practice Center Systematic Review Protocol
Project Title: Suicide Prevention
I. Background and Objectives for the Systematic Review
Despite advances in the diagnosis and treatment of major mental disord…
-
effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/clinician
August 31, 2016 - Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence
Clinician Summary Archived August 31, 2016 Download Main Document PDF 258.3 KB
Archived: This report is greater than 3 years old. Findings may be used for research p…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_clinician.pdf
August 01, 2016 - Psychosocial and Pharmacologic Interventions for Disruptive Behavior Disorders in Children and Adolescents: Current State of the Evidence
Psychosocial and Pharmacologic Interventions for Disruptive Behavior
Disorders in Children and Adolescents: Current State of the Evidence
Focus of This Summary
This is a summar…
-
effectivehealthcare.ahrq.gov/sites/default/files/adhd_executive.pdf
October 01, 2011 - 1991 to 1999, prescriptions
for MPH increased from 4 million to 11 million, and
prescriptions for amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-update_research-protocol.pdf
August 18, 2016 - ADHD-Update-protocol-160818
Source: www.effectivehealthcare.ahrq.gov
Published online: August 18, 2016
Evidence-based Practice Center Systematic Review Protocol
Project Title: Attention Deficit Hyperactivity Disorder (ADHD)
Initial publication date if applicable: Nov 25, 2015
Amendment Date(s) if applicabl…
-
effectivehealthcare.ahrq.gov/products/disruptive-behavior-disorder/consumer
August 31, 2016 - Treating Disruptive Behavior Disorders in Children and Teens
Consumer Summary Archived August 31, 2016 Download Main Document PDF 3.6 MB
Archived: This report is greater than 3 years old. Findings may be used for research purposes, but should not be considered current.
Is This Information Right…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disruptive-behavior-disorder_consumer.pdf
August 01, 2016 - Treating Disruptive Behavior Disorders in Children and Teens
Treating Disruptive Behavior
Disorders in Children and Teens
A Review of the Research for Parents and Caregivers
e
Is This Information Right for Me?
This information is for you if:
� A health care professional* said your child or teen has a
disrupti…
-
effectivehealthcare.ahrq.gov/products/ptsd-repository-expanded/protocol
February 14, 2020 - exp Amphetamines/
(amphetamine or armodafanil or atomoxetine or dexmethylphenidate or dextroamphetamine
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/adhd-heart-disease-adults_research.pdf
November 01, 2011 - Regression models were not fit for amphetamines, atomoxetine, and pemoline, because there was only one … Current User 373,667 7 1.87 0.75 0.31-1.85
Methylphenidate 192,257 4 2.08 0.96 0.31-2.97
Amphetamines … ‡Because of low numbers of events for use of amphetamines, atomoxetine, and pemoline, regression models
-
effectivehealthcare.ahrq.gov/sites/default/files/adhd_disposition-comments.pdf
October 01, 2011 - Attention Deficit Hyperactivity Disorder: Effectiveness of Treatment in At-Risk Preschoolers; Long-Term Effectiveness in All Ages; and Variability in Prevalence, Diagnosis, and Treatment
Source: http://www.effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-
reports/?pageaction=displayproduct&product…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorder_executive.pdf
October 01, 2015 - 1
Comparative Effectiveness Review
Number 154
Psychosocial and Pharmacologic Interventions
for Disruptive Behavior in Children and
Adolescents
Executive Summary
Background
Disruptive behavior disorders (DBDs) are
a group of related psychiatric disorders
of childhood and adolescence marked by
temper tantrums,…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ptsd-repository-expanded-protocol.pdf
October 24, 2019 - sertraline or trazadone or trimipramine or venlafaxine or vilazodone or vortioxetine).ti,ab.
24. exp Amphetamines
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-repository-expanded-protocol.pdf
October 24, 2019 - sertraline or trazadone or trimipramine or venlafaxine or vilazodone or vortioxetine).ti,ab.
24. exp Amphetamines
-
effectivehealthcare.ahrq.gov/products/ptsd-pharm-treatment/protocol
July 10, 2018 - exp Amphetamines/
(amphetamine or armodafanil or atomoxetine or dexmethylphenidate or dextroamphetamine